© 2020 RSM US LLP. All rights reserved.
Creating sustainable growth and profitability in life sciences
Insights and strategies to grow your life sciences business
A strong business growth plan can mean weighing a variety of factors, including shifting demographics, pricing pressures, capital and funding options, strategic mergers and acquisitions, innovation demands, and more.
To position for expansion and profitability, growing life sciences companies can maximize valuation by creating new products and services to meet changing consumers’ needs, enhancing infrastructure and financial systems, outsourcing the right tasks and operations, and leveraging key tax credits and considerations.
RELATED INSIGHTS
INSIGHT ARTICLE
Life sciences finance leaders discuss strategies to scale businesses
From contract research organizations to initial public offerings, life sciences finance leaders discuss issues in the bioscience businesses.
ARTICLE
The critical blend of science and finance for bioscience businesses
Bioscience insiders share why balancing science, as well as finance and accounting, is essential for growing biotechs.
WHITE PAPER
Finance transformation in the pharmaceutical industry
Commercializing new drugs is more challenging than ever, but increasing focus on your finance function can better manage a difficult
INFOGRAPHIC
Top 7 ways outsourcing can help keep your focus on the science
Life sciences companies, learn how you can get the most out of your outsourcing relationships and keep your focus on the science
INSIGHT ARTICLE
Understanding R&D credit benefits for the life sciences industry
Resources to help you gain an understanding of the eligibility criteria and re-examine your eligibility for the R&D credit.
CASE STUDY
Valuation needs in the life sciences industry are anything but generic
This case study focuses on the importance of a deep understanding in life sciences company valuations. Learn more.
INSIGHT ARTICLE
Investing in the Medical Device and Life Sciences industry?
Because competition is fierce, understanding strategic fit is key to ensuring returns on your life sciences and medical device investment.